Why the study?
General anesthesia and surgery can impact metabolic status, but their exact effects on the systemic metabolome remain unclear and may contribute to postoperative outcomes.
Does the amount of sevoflurane exposure during abdominal surgery impact the systemic metabolome?
Does the amount of sevoflurane exposure during abdominal surgery impact the systemic metabolome?
Sevoflurane anesthesia and abdominal surgery impact principal metabolic pathways, with specific metabolite changes correlating with the amount of sevoflurane exposure.
Sevoflurane anesthesia and abdominal surgery alter systemic metabolism; leaves open whether these changes affect postoperative outcomes or warrant practice changes.
Background Metabolic status can be impacted by general anesthesia and surgery. However, the exact effects of general anesthesia and surgery on systemic metabolome remain unclear, which might contribute to postoperative outcomes. Methods Five hundred patients who underwent abdominal surgery were included. General anesthesia was mainly maintained with sevoflurane. The end-tidal sevoflurane concentration (ET sevo ) was adjusted to maintain BIS (Bispectral index) value between 40 and 60. The mean ET sevo from 20 min after endotracheal intubation to 2 h after the beginning of surgery was calculated for each patient. The patients were further divided into low ET sevo group (mean − SD) and high ET sevo group (mean + SD) to investigate the possible metabolic changes relevant to the amount of sevoflurane exposure. Results The mean ET sevo of the 500 patients was 1.60% ± 0.34%. Patients with low ET sevo ( n = 55) and high ET sevo ( n = 59) were selected for metabolomic analysis (1.06% ± 0.13% vs. 2.17% ± 0.16%, P < 0.001). Sevoflurane and abdominal surgery disturbed the tricarboxylic acid cycle as identified by increased citrate and cis-aconitate levels and impacted glycometabolism as identified by increased sucrose and D-glucose levels in these 114 patients. Glutamate metabolism was also impacted by sevoflurane and abdominal surgery in all the patients. In the patients with high ET sevo , levels of L-glutamine, pyroglutamic acid, sphinganine and L-selenocysteine after sevoflurane anesthesia and abdominal surgery were significantly higher than those of the patients with low ET sevo , suggesting that these metabolic changes might be relevant to the amount of sevoflurane exposure. Conclusions Sevoflurane anesthesia and abdominal surgery can impact principal metabolic pathways in clinical patients including tricarboxylic acid cycle, glycometabolism and glutamate metabolism. This study may provide a resource data for future studies about metabolism relevant to general anaesthesia and surgeries. Trial registration www.chictr.org.cn . identifier: ChiCTR1800014327 .
No takes yet. Share an insight, caveat, or question.
Wei et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: